NO994274D0 - Sammensetninger til Õ behandle tumörer inneholdende haibruskekstrakter og antineoplastiske forbindelser - Google Patents

Sammensetninger til Õ behandle tumörer inneholdende haibruskekstrakter og antineoplastiske forbindelser

Info

Publication number
NO994274D0
NO994274D0 NO994274A NO994274A NO994274D0 NO 994274 D0 NO994274 D0 NO 994274D0 NO 994274 A NO994274 A NO 994274A NO 994274 A NO994274 A NO 994274A NO 994274 D0 NO994274 D0 NO 994274D0
Authority
NO
Norway
Prior art keywords
compositions
shark cartilage
treat tumors
tumors containing
antineoplastic compounds
Prior art date
Application number
NO994274A
Other languages
English (en)
Other versions
NO322847B1 (no
NO994274L (no
Inventor
Eric Dupont
Original Assignee
Aeterna Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeterna Lab Inc filed Critical Aeterna Lab Inc
Publication of NO994274D0 publication Critical patent/NO994274D0/no
Publication of NO994274L publication Critical patent/NO994274L/no
Publication of NO322847B1 publication Critical patent/NO322847B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19994274A 1997-03-11 1999-09-02 Sammensetninger til a behandle tumorer inneholdende haibruskekstrakter og platinaholdige antineoplastiske forbindelser, sett som inneholder doseformer av sammensetningen og anvendelse av sammensetningen til a fremstille et legemiddel. NO322847B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2199694 1997-03-11
PCT/CA1998/000202 WO1998040088A1 (en) 1997-03-11 1998-03-11 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents

Publications (3)

Publication Number Publication Date
NO994274D0 true NO994274D0 (no) 1999-09-02
NO994274L NO994274L (no) 1999-11-09
NO322847B1 NO322847B1 (no) 2006-12-11

Family

ID=4160148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994274A NO322847B1 (no) 1997-03-11 1999-09-02 Sammensetninger til a behandle tumorer inneholdende haibruskekstrakter og platinaholdige antineoplastiske forbindelser, sett som inneholder doseformer av sammensetningen og anvendelse av sammensetningen til a fremstille et legemiddel.

Country Status (19)

Country Link
US (2) US6383522B1 (no)
EP (1) EP0967987B1 (no)
JP (1) JP2001500899A (no)
KR (1) KR100417612B1 (no)
CN (2) CN1245993C (no)
AT (1) ATE241993T1 (no)
AU (1) AU745769B2 (no)
BR (1) BR9808858A (no)
CA (1) CA2281570C (no)
DE (1) DE69815310T2 (no)
DK (1) DK0967987T3 (no)
ES (1) ES2200316T3 (no)
HK (1) HK1026364A1 (no)
IL (1) IL131701A (no)
NO (1) NO322847B1 (no)
NZ (1) NZ337376A (no)
PT (1) PT967987E (no)
RU (1) RU2195946C2 (no)
WO (1) WO1998040088A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
JP2005508322A (ja) * 2001-09-24 2005-03-31 ジェシー エル エス オウ 併用療法に用いられるスラミンの化学増感用量を決定するための方法及び成分
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
WO2004083257A1 (ja) * 2003-03-20 2004-09-30 Hosokawa Micron Corporation 軟骨魚類から単離されたプロテオグリカンおよびその製造方法
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
EP1912675B1 (en) 2005-07-25 2014-02-12 Emergent Product Development Seattle, LLC B-cell reduction using cd37-specific and cd20-specific binding molecules
JP4834671B2 (ja) 2005-09-29 2011-12-14 株式会社マルハニチロ水産 成人病の予防及び治療に有効な組成物
US8409577B2 (en) 2006-06-12 2013-04-02 Emergent Product Development Seattle, Llc Single chain multivalent binding proteins with effector function
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US20090148447A1 (en) * 2007-07-06 2009-06-11 Trubion Pharmaceuticals, Inc. Binding Peptides Having a C-terminally Disposed Specific Binding Domain
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
JP6013733B2 (ja) * 2008-04-11 2016-10-25 エマージェント プロダクト デベロップメント シアトル， エルエルシー Ｃｄ３７免疫治療薬および二機能性化学療法薬とのその組合せ
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
KR20180053322A (ko) 2015-09-21 2018-05-21 압테보 리서치 앤드 디벨롭먼트 엘엘씨 Cd3 결합 폴리펩타이드
WO2017201200A1 (en) * 2016-05-19 2017-11-23 Orphagen Pharmaceuticals, Inc. Therapeutic compositions containing rar-alpha antagonists

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28093E (en) 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3478146A (en) 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US3966908A (en) 1973-11-29 1976-06-29 Lescarden Ltd. Method of treating degenerative joint afflictions
US4042457A (en) 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4212857A (en) 1976-10-29 1980-07-15 Lescarden Ltd. Method for stimulating the production of immunoglobulin and total complement
US4822607A (en) 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4243582A (en) 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4456589A (en) 1982-07-08 1984-06-26 Genetic Laboratories, Inc. Preparation of animal tissues for surgical implantation in human recipients
US4473551A (en) 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
JPS5939828A (ja) 1982-08-28 1984-03-05 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4444752A (en) 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4469676A (en) 1983-06-21 1984-09-04 Michel Hecmati Method for eliminating wrinkles occurring in the human skin
JPS60178820A (ja) 1984-02-22 1985-09-12 Ajinomoto Co Inc 抗腫瘍活性物質の製造方法
US4656137A (en) 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
US5096892A (en) 1988-05-27 1992-03-17 The Children's Medical Center Corporation Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
US5075112A (en) 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
CA2100657A1 (en) 1991-11-15 1993-05-16 Glen M. Hartung Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals
AU5596494A (en) 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
KR101222904B1 (ko) 1993-07-19 2013-01-17 안지오테크 파마슈티칼즈, 인코포레이티드 항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
US5618925A (en) 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US5583153A (en) 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
US5843920A (en) 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof

Also Published As

Publication number Publication date
ATE241993T1 (de) 2003-06-15
KR20000075929A (ko) 2000-12-26
IL131701A (en) 2005-03-20
AU745769B2 (en) 2002-03-28
WO1998040088A1 (en) 1998-09-17
CN1245993C (zh) 2006-03-22
PT967987E (pt) 2003-10-31
NO322847B1 (no) 2006-12-11
DE69815310D1 (de) 2003-07-10
NZ337376A (en) 2002-02-01
CA2281570C (en) 2003-09-23
HK1026364A1 (en) 2000-12-15
IL131701A0 (en) 2001-03-19
CA2281570A1 (en) 1998-09-17
ES2200316T3 (es) 2004-03-01
US20020146462A1 (en) 2002-10-10
CN1250375A (zh) 2000-04-12
CN1824317A (zh) 2006-08-30
AU6605598A (en) 1998-09-29
KR100417612B1 (ko) 2004-02-05
JP2001500899A (ja) 2001-01-23
DE69815310T2 (de) 2004-04-22
NO994274L (no) 1999-11-09
EP0967987B1 (en) 2003-06-04
DK0967987T3 (da) 2003-09-22
RU2195946C2 (ru) 2003-01-10
EP0967987A1 (en) 2000-01-05
US6855338B2 (en) 2005-02-15
BR9808858A (pt) 2000-08-01
US6383522B1 (en) 2002-05-07

Similar Documents

Publication Publication Date Title
NO994274D0 (no) Sammensetninger til Õ behandle tumörer inneholdende haibruskekstrakter og antineoplastiske forbindelser
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
DK1663242T3 (da) 2,4-Pyrimidindiamin-forbindelser og anvendelse som antiproliferative midler
DK1129093T3 (da) Pyrazolopyrimidinonderivater til behandling af impotens
DE69905170D1 (en) Thiazolopyrimidinderivate
ID21529A (id) Metode dan komposisi untuk pengobatan dan pencegahan tumor, gangguan yang berhubungan dengan tumor dan kakeksia
ES2036553T3 (es) Composiciones farmaceuticas que tienen actividad antineoplastica.
DK1112067T3 (da) Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer
NZ507350A (en) Semi-synthetic ecteinascidins and use in treatment of tumors
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
EP1017675A4 (en) HIGHLY LIPOPHILIC CAMPTOTHECIN DERIVATIVES
BR9912327A (pt) Inibidores da uroquinase
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
SE9802937D0 (sv) Novel compounds
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
BR0111785A (pt) Composições e métodos para tratamento de candidìase
BR0114604A (pt) Tratamento de c‰nceres
IL139144A0 (en) Mycobacterial inhibitors
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
MXPA03002494A (es) Metodo para reducir toxicidad de quimio terapias combinadas.
AU1128801A (en) Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth
TR199802496T2 (xx) Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.